Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Products & Services, Research & Development

TITLE:

EMA's Pharmacovigilance Risk Assessment Committee (PRAC) assessed known risk of pneumonia with inhaled corticosteroids for chronic obstructive pulmonary disease

BRIEF:

Report finds no differences in this risk between products.

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company